Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Arab
Amir Arab, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20100220006 | GLOBAL POSITIONING SYSTEMS BASED DISCIPLINED REFERENCE CLOCK - A disciplined reference clock generating a frequency accurate clock signal based on a reference pulse generated by a global positioning system is provided. Clock circuitry and processes are also provided to ensure frequency locking and signal validity of the generated clock signal. | 09-02-2010 |
Lakhdar Arab, Vancouver CA
| Patent application number | Description | Published |
|---|---|---|
| 20090192082 | CXCR4 ANTAGONIST TREATMENT OF HEMATOPOIETIC CELLS - Compositions comprising a peptide consisting of an amino acid sequence derived from a P2G-substituted SDF-1 protein are taught. The amino acid sequence consists of a first sequence consisting of 8 to 17 amino acids from the N-terminal portion of the SDF-1 protein and having a conserved KGVS motif. The amino acid sequences may also consist of one or more optional components selected from the group consisting of a second sequence consisting of 8 to 17 amino acids from the N-terminal portion of the SDF-1 protein and having a conserved KGVS motif, wherein the second sequence is covalently joined to the first sequence with or without a linker; and, a third sequence consisting of LKWIQEYLEKALN, or conservative substitutions thereof, wherein the third sequence is covalently joined to the first sequence with the linker. Methods of increasing multiplication of hematopoietic cells and enhancing proliferation of hematopoietic cells during engraftment are also taught. | 07-30-2009 |
| 20110118193 | TREATMENT OF LIQUID CANCERS - A use of a composition comprising an SDF-1 peptide having the sequence KGVSLSYR is taught. The composition can be used in the manufacture of a medicament for the treatment of a blood cancer in a mammal by administering the medicament in a therapeutically effective amount. | 05-19-2011 |
| 20110230422 | PURGING OF AN EX VIVO HEMATOPOIETIC STEM CELL CULTURE OF CANCER CELLS - A use of a composition comprising an SDF-1 peptide having the sequence KGVSLSYR is taught. The composition can be used to purge an ex vivo hematopoietic stem cell culture of cancer cells for engraftment in a mammal by administering the composition to the ex vivo hematopoietic stem cell culture in an effective amount. | 09-22-2011 |
Nicolas Arab, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120019536 | METHODS, STORAGE MEDIUMS, AND SYSTEMS FOR ANALYZING PARTICLE QUANTITY AND DISTRIBUTION WITHIN AN IMAGING REGION OF AN ASSAY ANALYSIS SYSTEM AND FOR EVALUATING THE PERFORMANCE OF A FOCUSING ROUTING PERFORMED ON AN ASSAY ANALYSIS SYSTEM - Methods, storage mediums and systems (MS&S) are provided which successively image an imaging region of an assay analysis system (AAS) as particles are loaded into the imaging region, generate a frequency spectrum of each image via a discrete Fourier transform, integrate a same coordinate portion of each frequency spectrum and terminate the loading of particles upon computing an integral which meets preset criterion. In addition, MS&S are provided which send a signal indicative of whether enough particles are in an imaging region for further processes by an AAS based on the magnitude of integral calculated from an image's frequency spectrum. MM&S are also provided such that the steps of generating a frequency spectrum of each image and integrating a portion of each frequency spectrum are replaced by generating a convolved spatial image with a filter kernel and integrating a same coordinate portion of each convolved spatial image. | 01-26-2012 |
Nicolas F. Arab, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100228513 | Systems and Methods for Performing Measurements of One or More Materials - Systems and methods for performing measurements of one or more materials are provided. One system is configured to transfer one or more materials to an imaging volume of a measurement device from one or more storage vessels. Another system is configured to image one or more materials in an imaging volume of a measurement device. An additional system is configured to substantially immobilize one or more materials in an imaging volume of a measurement device. A further system is configured to transfer one or more materials to an imaging volume of a measurement device from one or more storage vessels, to image the one or more materials in the imaging volume, to substantially immobilize the one or more materials in the imaging volume, or some combination thereof. | 09-09-2010 |
Ra'Ed Arab, Ottawa CA
| Patent application number | Description | Published |
|---|---|---|
| 20100218806 | CONCENTRATED SOLAR SYSTEM - There is provided a concentrating solar collector in the shape of an inverted truncated pyramid (collector) with light reflective surfaces on the inside. The collector includes a large top opening which is pointed towards the sun collecting the sun rays. A high-concentration photovoltaic solar cell is placed at the narrow end of the collector. The light is concentrated onto the solar cell, which generates electricity from the concentrated solar light. The collector is made of, but not limited to, an inflatable lightweight reflective film, balloon filled with helium, glass, plastic or metal. The reflective surface inside the collector is obtained using inexpensive mirror coating which is applied to clear glass or plastic. A cooling system is used for keeping the concentrated photovoltaic solar cell at or close to a fixed temperature to maintain the cell at its highest operating efficiency of power generation. | 09-02-2010 |
Sara Arab, Toronto CA
| Patent application number | Description | Published |
|---|---|---|
| 20110027819 | USE OF SFRP-3 IN THE ASSESSMENT OF HEART FAILURE - Disclosed is a method for assessing heart failure in vitro including the steps of measuring in a sample the concentration of the marker SFRP-3, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for SFRP-3 and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of SFRP-3 as a marker protein in the assessment of heart failure, a marker combination comprising SFRP-3 and a kit for measuring SFRP-3. | 02-03-2011 |
| 20110165591 | USE OF BIGLYCAN IN THE ASSESSMENT OF HEART FAILURE - The invention relates to a method for assessing heart failure in vitro and involves the steps of measuring in a sample the concentration of the marker biglycan, of optionally measuring in the sample the concentration of one or more other marker(s) of heart failure, and of assessing heart failure by comparing the concentration determined in for biglycan and the concentration(s) determined for the optionally one or more other marker to the concentration of this marker or these markers as established in a reference population. Also disclosed are the use of biglycan as a marker protein in the assessment of heart failure, a marker combination comprising biglycan and a kit for measuring biglycan. | 07-07-2011 |